levothyroxine sodium 50 MCG in 1 mL Oral Solution
- RxCUI
- 2056468
- RxNorm name
- levothyroxine sodium 50 MCG in 1 mL Oral Solution
- Display name
- levothyroxine sodium 50 MCG in 1 mL Oral Solution
- Full name
- levothyroxine sodium 50 MCG in 1 mL Oral Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tirosint SOL | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 2056468 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5d378add-f13d-40f2-99dc-0f2340ab44b7 | levothyroxine sodium 50 MCG in 1 mL Oral Solution | PSN | 18 | These highlights do not include all the information needed to use TIROSINT ® -SOL safely and effectively. See full prescribing information for TIROSINT ® -SOL. Initial U.S. Approval: 2000 | 20260327 |
| 5d378add-f13d-40f2-99dc-0f2340ab44b7 | levothyroxine sodium 50 MCG per 1 ML Oral Solution | SY | 18 | These highlights do not include all the information needed to use TIROSINT ® -SOL safely and effectively. See full prescribing information for TIROSINT ® -SOL. Initial U.S. Approval: 2000 | 20260327 |
| 5d378add-f13d-40f2-99dc-0f2340ab44b7 | levothyroxine sodium 0.05 MG/ML Oral Solution | SCD | 18 | These highlights do not include all the information needed to use TIROSINT ® -SOL safely and effectively. See full prescribing information for TIROSINT ® -SOL. Initial U.S. Approval: 2000 | 20260327 |